Posted by Larry Hoover on February 14, 2007, at 20:18:05
In reply to Re: Sanofi-Aventis Progress Report » Larry Hoover, posted by jealibeanz on February 14, 2007, at 19:34:27
> Well... if you look at this site, SR 58611 has asupplemental NDA possible in 2007. So I'm confused.
>
> http://www.neurotransmitter.net/newdrugs.htmlThis particular compound has been around for about twenty years, and has already gone through phase I and II trials. By using a supplemental application, they only need to show efficacy for a new indication, e.g. depression, rather than the original NDA which was for irritable bowel syndrome. Makes you wonder what the side effects of this one might be, as there are two kinds of IBS.....diarrhea predominant and constipation predominant (as well as one that alternates, which some argue is a variant of the constipation predominant). Anyway, I digress.
Lar
poster:Larry Hoover
thread:732825
URL: http://www.dr-bob.org/babble/20070213/msgs/732895.html